Inovio Pharmaceuticals (INO) Other Non-Current Liabilities (2010 - 2022)
Inovio Pharmaceuticals (INO) recorded Other Non-Current Liabilities of $710,348 in Q3 2022, compared with $64,141 a year earlier.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Other Non-Current Liabilities (2010 - 2022) Analysis & Trends
At the end of FY2021, Inovio Pharmaceuticals reported Other Non-Current Liabilities of $14,826, down 74.3% from FY2020.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -69.8% (FY2016 to FY2021).
- Across earlier years, Other Non-Current Liabilities came in at $57,663 in FY2020 (-99.3%), $8.82 million in FY2019 (+3.5%), $8.52 million in FY2018 (-6.4%) and $9.1 million in FY2017 (+53.6%).
- The Q3 2022 figure is the highest quarterly Other Non-Current Liabilities since Q2 2020.
- On a year-over-year basis, Other Non-Current Liabilities rose in 1 of the last five quarters, with an average decline of 62.4%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 61.3% in Q3 2021, against a decline of 99.9% in Q2 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 68.56 Mn | -115.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 710,348.00 |
| Dec 31, 2021 | 14,826.00 |
| Sep 30, 2021 | 64,141.00 |
| Jun 30, 2021 | 64,141.00 |
| Mar 31, 2021 | 64,141.00 |
| Dec 31, 2020 | 57,663.00 |
| Sep 30, 2020 | 39,776.00 |
| Jun 30, 2020 | 119.86 Mn |
| Mar 31, 2020 | 22.11 Mn |
| Dec 31, 2019 | 8.86 Mn |
| Sep 30, 2019 | 4.55 Mn |
| Jun 30, 2019 | 50,762.00 |
| Mar 31, 2019 | 64,257.00 |
| Dec 31, 2018 | 8.61 Mn |
| Sep 30, 2018 | 8.77 Mn |
| Jun 30, 2018 | 9.05 Mn |
| Mar 31, 2018 | 9.46 Mn |
| Dec 31, 2017 | 9.47 Mn |
| Sep 30, 2017 | 8.80 Mn |
| Jun 30, 2017 | 8.92 Mn |
API Access
Inovio Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();